Guardant Health Overview
Guardant Health Target Price
Analysts' average 12-month price target for Guardant Health is $190.
Get informed when a big investor buys or sells
+ FollowShare Price
$177.8
Average Target Price
$192.04
8% upside
8% upside25 analysts in the last 4 months
High: $225 | Low: $150
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-10-01 | Guggenheim | $200 | 12.5% upside |  |
| 2026-09-10 | BernsteinEve Burstein | $210 | 18.1% upside | |
| 2026-09-09 | UBS | $225 | 26.5% upside | |
| 2026-09-08 | Redburn Partners | $203 | 14.2% upside | |
| 2026-08-04 | Piper Sandler | $193 | 8.5% upside | |
| 2026-08-04 | Morgan Stanley | $185 | 4% upside | |
| 2026-08-04 | Stephens | $195 | 9.7% upside | |
| 2026-07-31 | Barclays | $200 | 12.5% upside | |
| 2026-07-31 | RBC CapitalDan Leonard | $200 | 12.5% upside | |
| 2026-07-31 | RBC Capital | $210 | 18.1% upside | |
| 2026-07-31 | Stifel NicolausDaniel Arias | $180 | 1.2% upside | |
| 2026-07-31 | Goldman Sachs | $210 | 18.1% upside | |
| 2026-07-31 | Mizuho SecuritiesAnthony Petrone | $200 | 12.5% upside | |
| 2026-07-31 | BTIGMark Massaro | $195 | 9.7% upside | |
| 2026-07-16 | Guggenheim | $190 | 6.9% upside | |
| 2026-07-14 | Canaccord GenuityKyle Mikson | $205 | 15.3% upside | |
| 2026-07-09 | Morgan Stanley | $175 |  1.6% downside | |
| 2026-07-06 | Evercore ISIVijay Kumar | $200 | 12.5% upside | |
| 2026-07-02 | BernsteinEve Burstein | $200 | 12.5% upside | |
| 2026-07-01 | BTIG | $190 | 6.9% upside | |
| 2026-06-29 | Guggenheim | $160 | 10% downside | |
| 2026-06-24 | UBS | $150 | 15.6% downside | |
| 2026-06-11 | RBC CapitalDan Leonard | $185 | 4% upside | |
| 2026-06-08 | Mizuho Securities | $175 | 1.6% downside | |
| 2026-06-05 | Goldman SachsEvie Koslosky | $165 | 7.2% downside | |
| 2026-06-02 | Evercore ISI | $160 | 10% downside | |
| 2026-05-27 | BTIG | $160 | 10% downside | |
| 2026-05-26 | BTIGMark Massaro | $155 | 12.8% downside | |
| 2026-05-21 | Piper Sandler | $127 | 28.6% downside | |
| 2026-05-12 | Piper SandlerDavid Westenberg | $135 | 24.1% downside | |
| 2026-04-14 | BarclaysLuke Sergott | $115 | 35.3% downside | |
| 2026-02-24 | Piper Sandler | $130 | 26.9% downside | |
| 2026-02-23 | Raymond James | $129 | 27.4% downside | |
| 2026-02-20 | Evercore ISI | $110 | 38.1% downside | |
| 2026-02-20 | BTIG | $145 | 18.4% downside | |
| 2026-02-20 | Stifel Nicolaus | $130 | 26.9% downside | |
| 2026-02-20 | Canaccord Genuity | $135 | 24.1% downside | |
| 2026-02-20 | Barclays | $130 | 26.9% downside | |
| 2026-02-17 | Robert W. BairdCatherine Schulte | $120 | 32.5% downside | |
| 2026-01-30 | UBS | $175 | 1.6% downside | |
| 2026-01-26 | Guggenheim | $135 | 24.1% downside | |
| 2026-01-09 | Mizuho Securities | $135 | 24.1% downside | |
| 2026-01-09 | Stifel Nicolaus | $120 | 32.5% downside | |
| 2026-01-05 | GuggenheimSubbu Nambi | $115 | 35.3% downside | |
| 2026-01-05 | Evercore ISIVijay Kumar | $105 | 40.9% downside | |
| 2025-12-22 | Canaccord Genuity | $125 | 29.7% downside | |
| 2025-12-17 | Mizuho Securities | $120 | 32.5% downside | |
| 2025-12-15 | Leerink Partners | $155 | 12.8% downside | |
| 2025-12-15 | Wells FargoBrandon Couillard | $120 | 32.5% downside | |
| 2025-12-15 | Barclays | $120 | 32.5% downside | |